Your browser is no longer supported. Please, upgrade your browser.
Settings
NURO NeuroMetrix, Inc. daily Stock Chart
NURO [NASD]
NeuroMetrix, Inc.
Index- P/E- EPS (ttm)-0.11 Insider Own3.63% Shs Outstand8.79M Perf Week3.28%
Market Cap4.70M Forward P/E- EPS next Y-0.22 Insider Trans0.00% Shs Float8.53M Perf Month-21.31%
Income0.90M PEG- EPS next Q-0.19 Inst Own11.70% Short Float2.49% Perf Quarter-49.53%
Sales14.30M P/S0.33 EPS this Y100.00% Inst Trans-5.86% Short Ratio1.08 Perf Half Y-39.89%
Book/sh1.06 P/B0.50 EPS next Y104.90% ROA6.90% Target Price5.00 Perf Year-57.20%
Cash/sh0.82 P/C0.65 EPS next 5Y15.00% ROE11.80% 52W Range0.48 - 1.77 Perf YTD-29.61%
Dividend- P/FCF- EPS past 5Y14.90% ROI-0.60% 52W High-69.72% Beta0.70
Dividend %- Quick Ratio2.00 Sales past 5Y25.00% Gross Margin43.40% 52W Low11.62% ATR0.07
Employees42 Current Ratio2.60 Sales Q/Q-36.70% Oper. Margin6.10% RSI (14)33.15 Volatility16.81% 11.33%
OptionableNo Debt/Eq0.00 EPS Q/Q72.80% Profit Margin6.40% Rel Volume0.44 Prev Close0.54
ShortableYes LT Debt/Eq0.00 EarningsJul 25 BMO Payout0.00% Avg Volume195.79K Price0.54
Recom2.50 SMA20-9.82% SMA50-29.05% SMA200-46.41% Volume58,316 Change0.17%
Oct-20-17Reiterated H.C. Wainwright Buy $10 → $3
Jun-28-16Initiated Rodman & Renshaw Buy $4.50
Sep-11-15Initiated Maxim Group Buy $2
Feb-27-12Initiated Dawson James Buy $3
May-21-19 01:00PM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology GlobeNewswire
May-07-19 01:00PM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology GlobeNewswire -8.88%
May-01-19 11:07PM  Edited Transcript of NURO earnings conference call or presentation 25-Apr-19 12:00pm GMT Thomson Reuters StreetEvents
Apr-28-19 10:05AM  If You Had Bought NeuroMetrix (NASDAQ:NURO) Stock Five Years Ago, You'd Be Sitting On A 99% Loss, Today Simply Wall St.
Apr-25-19 07:00AM  NeuroMetrix Reports Q1 2019 Financial Results GlobeNewswire -7.20%
06:00AM  NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Apr-18-19 10:33AM  Analysts Estimate NeuroMetrix (NURO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-17-19 11:00AM  NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call GlobeNewswire
Apr-12-19 10:30AM  Earnings Preview: NeuroMetrix (NURO) Q1 Earnings Expected to Decline Zacks
Mar-07-19 11:45AM  NeuroMetrix, Inc. (NASDAQ:NURO) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Jan-29-19 01:00PM  NeuroMetrix Reports New Clinical Studies Published on DPNCheck GlobeNewswire
Jan-28-19 11:55AM  NeuroMetrix, Inc. (NASDAQ:NURO): A Fundamentally Attractive Investment Simply Wall St.
08:24AM  Edited Transcript of NURO earnings conference call or presentation 24-Jan-19 1:00pm GMT Thomson Reuters StreetEvents
Jan-24-19 07:00AM  NeuroMetrix Reports Q4 and Full Year 2018 Financial Results GlobeNewswire -23.26%
Jan-22-19 01:00PM  NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain GlobeNewswire
Jan-16-19 01:00PM  Quell Reports Successful CES 2019 GlobeNewswire -6.77%
Jan-15-19 02:00PM  NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call GlobeNewswire +15.91%
Jan-08-19 01:30PM  Quell Named CES 2019 Innovation Awards Honoree GlobeNewswire +9.92%
Jan-07-19 07:00AM  NeuroMetrix Adds Artificial Intelligence, Coaching and New Therapy Option to Quell 2.0 For Personalized Pain Relief GlobeNewswire
Dec-27-18 01:30PM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology GlobeNewswire +11.43%
Dec-26-18 02:12PM  Analyst: NeuroMetrix Benefits From Alternative Pain Management Trend Benzinga
Dec-19-18 01:30PM  NeuroMetrix to Present at Upcoming Biotech Showcase 2019 In San Francisco GlobeNewswire
Dec-12-18 01:22PM  Is NeuroMetrix, Inc.s (NASDAQ:NURO) CEO Pay Fair? Simply Wall St. -12.67%
06:55AM  Today's Research Reports on Trending Tickers: NeuroMetrix and Moleculin ACCESSWIRE
Dec-11-18 01:30PM  NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration GlobeNewswire +19.89%
Nov-28-18 11:00AM  NeuroMetrix to Present at the LD Micro 11th Annual Main Event on December 5, 2018 GlobeNewswire
Nov-20-18 10:41AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology GlobeNewswire
Nov-15-18 12:50PM  NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market GlobeNewswire
08:15AM  Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint Residential Trust, Frequency Electronics, and Horizon Technology Finance Future Expectations, Projections Moving into 2018 GlobeNewswire
Oct-31-18 11:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology GlobeNewswire
Oct-19-18 11:43AM  Edited Transcript of NURO earnings conference call or presentation 17-Oct-18 12:00pm GMT Thomson Reuters StreetEvents
Oct-18-18 11:00AM  NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo GlobeNewswire
Oct-17-18 07:00AM  NeuroMetrix Reports Q3 2018 Financial Results GlobeNewswire -5.26%
06:00AM  NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Oct-10-18 11:00AM  NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call GlobeNewswire
Oct-05-18 02:12PM  Shareholders Should Check The Ownership Structure Of NeuroMetrix Inc (NASDAQ:NURO) Simply Wall St.
Oct-02-18 11:00AM  NeuroMetrix Reports Publication of New Clinical Study on Quell Wearable Pain Relief Technology GlobeNewswire
Sep-25-18 10:00AM  NeuroMetrix To Present Quell 2.0 at DTxDM East: The Digital Therapeutics and Digital Medicine Event in Boston GlobeNewswire
Sep-20-18 01:00PM  NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network GlobeNewswire
Sep-04-18 02:00PM  NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018 PR Newswire
Aug-29-18 01:00PM  NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB GlobeNewswire
Aug-28-18 11:00AM  NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference GlobeNewswire
Aug-27-18 01:30PM  NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City GlobeNewswire
Aug-23-18 01:30PM  NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018 GlobeNewswire
Aug-21-18 02:30PM  NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare GlobeNewswire
Jul-25-18 07:05AM  Free Research Report as Intuitive Surgical's Revenues Jumped 20%; Non-GAAP EPS Surged 38% ACCESSWIRE
Jul-21-18 12:48AM  Edited Transcript of NURO earnings conference call or presentation 19-Jul-18 12:00pm GMT Thomson Reuters StreetEvents
Jul-19-18 07:00AM  NeuroMetrix Reports Q2 2018 Financial Results GlobeNewswire -12.41%
06:00AM  NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Jul-12-18 11:00AM  NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call GlobeNewswire
Jul-05-18 01:00PM  NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology GlobeNewswire
Jun-28-18 12:27PM  NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards GlobeNewswire
Jun-26-18 11:00AM  NeuroMetrix Reports Publication of New Clinical Studies on DPNCheck GlobeNewswire +7.75%
Jun-21-18 11:00AM  NeuroMetrix Report Highlights Stigma Faced by Chronic Pain Community around Opioid Use, Desire for Alternative Treatments GlobeNewswire
Jun-20-18 08:00AM  Today's Research Reports on Stocks to Watch: Neptune Technologies & Bioressources and NeuroMetrix ACCESSWIRE -8.78%
Jun-19-18 08:44AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +19.26%
07:00AM  NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare GlobeNewswire
Jun-11-18 06:12PM  Is NeuroMetrix Incs (NASDAQ:NURO) CEO Paid At A Competitive Rate? Simply Wall St.
May-24-18 12:27PM  NeuroMetrix Inc (NASDAQ:NURO): What Does It Mean For Your Portfolio? Simply Wall St.
May-11-18 07:10AM  Free Technical Snapshots for Ekso Bionics and Three More Medical Supplies Stocks ACCESSWIRE
May-03-18 11:00AM  Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress GlobeNewswire
May-01-18 11:00AM  NeuroMetrix, Inc. to Participate in Upcoming Disruptive Growth & Healthcare Conference in New York City GlobeNewswire
Apr-24-18 11:00AM  NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting GlobeNewswire
Apr-19-18 07:00AM  NeuroMetrix Reports Q1 2018 Financial Results GlobeNewswire -7.05%
06:15AM  NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Apr-18-18 02:00PM  NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting GlobeNewswire
Apr-11-18 11:00AM  NeuroMetrix, Inc. Announces Date for 2018 First Quarter Financial Results Conference Call GlobeNewswire -6.90%
Apr-10-18 02:30PM  NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief GlobeNewswire +9.02%
Mar-08-18 02:35PM  Should You Buy NeuroMetrix Inc (NASDAQ:NURO) Now? Simply Wall St.
Mar-01-18 11:00AM  NeuroMetrix to Present Quell Data at 2018 American Pain Society Meeting GlobeNewswire
Feb-08-18 01:48PM  NeuroMetrix Inc (NURO) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com -5.44%
Jan-25-18 06:09PM  Edited Transcript of NURO earnings conference call or presentation 25-Jan-18 1:00pm GMT Thomson Reuters StreetEvents -9.18%
07:00AM  NeuroMetrix Reports Q4 and Full Year 2017 Financial Results GlobeNewswire
Jan-19-18 07:40AM  Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval ACCESSWIRE -7.21%
Jan-18-18 11:40AM  NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call GlobeNewswire
Jan-17-18 02:13PM  Heres Why Neurometrix Inc Rose as Much as 60% Today SmarterAnalyst +20.35%
11:17AM  7 Stocks Move in Premarket Trade Wednesday GuruFocus.com
07:25AM  NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell MarketWatch
07:00AM  NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology GlobeNewswire
Jan-08-18 07:00AM  NeuroMetrix Reports Preliminary 2017 Financial Highlights GlobeNewswire
Jan-04-18 11:00AM  NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis GlobeNewswire +6.29%
Jan-03-18 11:00AM  NeuroMetrix to Present at Upcoming Biotech Showcase and Digital Medicine Showcase Conferences GlobeNewswire
Nov-29-17 10:09AM  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology Business Wire -14.43%
Nov-16-17 10:27AM  Interested In The Healthcare Industry? Take A Look At NeuroMetrix Inc (NURO) Simply Wall St. +8.81%
Nov-01-17 02:45PM  What Is NeuroMetrix Incs (NURO) Share Price Doing? Simply Wall St.
Oct-31-17 10:07AM  NeuroMetrix Closes $3.5 Million Equity Offering Business Wire
Oct-24-17 08:42AM  NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q3, 2017 By the Numbers : October 24, 2017 Capital Cube
Oct-20-17 01:31AM  Edited Transcript of NURO earnings conference call or presentation 19-Oct-17 12:00pm GMT Thomson Reuters StreetEvents
Oct-19-17 07:00AM  NeuroMetrix Reports Q3 2017 Financial Results Business Wire -8.99%
06:00AM  Investor Network: NeuroMetrix, Inc. to Host Earnings Call ACCESSWIRE
Oct-10-17 10:00AM  NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call Business Wire
Sep-18-17 03:37PM  Before You Buy NeuroMetrix Incs (NURO), You Should Consider This Simply Wall St.
Sep-05-17 01:00PM  NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017 Business Wire
Aug-31-17 03:32PM  Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference Business Wire
Aug-29-17 09:53AM  NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain Business Wire
Aug-17-17 07:40AM  Featured Company News - NeuroMetrix Announces Issuance of New US Patent for Automated Control of Quell(R) Therapy During Sleep ACCESSWIRE
Aug-15-17 07:00AM  NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep Business Wire
Aug-13-17 12:55AM  Edited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-03-17 10:13AM  NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan Business Wire
Jul-27-17 01:01PM  NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015 Business Wire
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gozani ShaiPresident & CEOOct 29Sale1.183,7604,437153,803Oct 29 04:05 PM